LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

13-Oxa prostaglandins for the treatment of glaucoma and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

13-substituted methacycline compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

13-substituted methacycline compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

13-substituted milbemycin 5-oxime derivatives, their preparation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

13-substituted milbemycin derivatives, their preparation and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

13-Thia prostaglandins for use in glaucoma therapy

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai

13-thiaprostaglandins having cytoprotective activity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

13.alpha.-alkyl-gonanes, their production, and pharmaceutical pr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

13.beta.-alkylmilbemycin derivatives for controlling parasites o

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

13.beta.-milbemycin derivatives for controlling ecto- and endopa

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14 β, 16, 17-methylene steroids as novel androgens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

14 and 15 membered ring compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14&bgr;,15&bgr;-methylene-17&agr;-hydroxymethyl-androgens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14, 15-.&agr;.-methylene equilenine derivatives, methods for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14, 15-cyclopropanosteroids of the 19-norandrostane series,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14,16.beta.-ethano-15.beta., 16(1)-cyclo-14.beta.-estra-1,3,5(10

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14,17.alpha.-etheno- and -ethanoestratrienes, processes for the

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

14,17.beta.-ethano-14.beta.-estratrienes and estratetraenes, pro

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

14- and 15-hydroxy milbemycin derivatives for controlling plant